ClinicalTrials.gov term: Pulmonary Disease, Chronic Obstructive
COPD clinical trials
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-08
What changed in the last 30 days
77 trials changed in the last 30 days: 2 stopped, 32 with notable changes, 43 with minor changes only.
-
Minor: 13 trials marked Unknown by the registry's verification sweep Changed
- Minor: QUANTUM · Quest to Analyze One Thousand Humans Meditating Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Enrolling by Invitation
- Minor: Use of Diaphragmatic Ultrasonography in Mechanical Ventilation Weaning Decision in COPD Patient Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Minor: Impact of HI-NPPV Vs LI-NPPV on Tolerance Among AECOPD Patients Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Minor: Presentation and Outcome of COPD · Acute Exacerbation Attending Sohag University Hospital Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Minor: Telerehabilitation · Chronic Obstructive Pulmonary Disease in Nuuk Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Minor: EntMedPall · Improving Pharmacological Transition of Palliative Care Patients From Inpatient to Outpatient Care Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: Transbronchial Bronchoscopic Thermal Vapor Ablation (BTVA) in Heterogeneous Emphysema Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Minor: Breather in COPD · Intermittent Claudication Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: Bufei Yishen Prescription on · Frequent AECOPD in Stable Stage Changed Registry marked status Unknown (sponsor has not verified the record since Mar 2024); last known: Not Yet Recruiting
- Minor: Air Filtration for COPD in VA Population of Veterans Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Active, Not Recruiting
- Minor: UNDATED · Sonographic Diaphragm Function in AECOPD Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: Telerehabilitation in COPD Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Minor: COPD-SAFE · Closed Loop Ventilation With High Tidal Volumes and Safe Transpulmonary Pressure in COPD Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting
- Notable: THERMA-LUNG · THERMotherapy Against Persistent Bacterial LUNG Infections Primary and study completion pushed from Dec 31, 2029 to Oct 31, 2032
- Notable: ENHANCE-3 · Ensifentrine (MK-5884) Study · Chronic Obstructive Pulmonary Disease (COPD) Exacerbations in Adults With a History of Moderate or Severe Exacerbations While Receiving Standard of Care (SOC) (MK-5884-031/RPL554/ENHANCE-3) Recruitment opened
- Notable: LANDCAP-1 · Local Antibiotic Delivery for Community Acquired Pneumonia Primary completion date changed from estimate of Sep 1, 2025 to Mar 17, 2026
- Minor: Symptoms and Functions · COPD and Chronic Bronchitis Switching From CIG to THS Primary completion pushed from Aug 2026 to Feb 2027
- Minor: SCALA · 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study · Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis Trial sites expanded: 23 → 26 locations
- Minor: CHRONOBIO · Time of Exercise Re-training With Chronic Obstructive Pulmonary Disease (COPD) Study completion pushed from Jul 1, 2026 to Mar 1, 2027
- Notable: Influence of FreeO2 on Percentage of Time Within Oxygen Saturation Target Using Noninvasive Ventilation (NIV) and Continuous Positive Airway Pressure (CPAP) for Patients Admitted for AECOPD or Bariatric Surgery Primary completion pushed from Jul 2027 to Jul 2028
- Notable: Interfaces · Several Oxygenation Targets With Different Oxygen Interfaces - Impact on Oxygen Flow Rates Primary completion pushed from Jun 2025 to Jun 2027
- Minor: GSK5784283 (Felcorekibart) Compared With Placebo · Moderate to Very Severe COPD (PERSIST COPD-2) Trial sites expanded: 4 → 8 locations
- Minor: GSK5784283 (Felcorekibart) Compared With Placebo · Moderate to Very Severe COPD (PERSIST COPD-1) Trial sites expanded: 2 → 7 locations
- Minor: WINDSURFER · WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department Trial sites expanded: 6 → 9 locations
- Notable: Impact of Maximal Strength Training · COPD Primary completion pushed from May 30, 2026 to Feb 28, 2027
- Notable: NAPOLEON · Comprehensive Maintenance Program: a Health Haven for COPD in Lleida.The NAPOLEON Project Primary completion pushed from Oct 2026 to Oct 2027
- Notable: Ensifentrine (MK-5884/RPL554) on Sputum Markers of Inflammation in Chronic Obstructive Pulmonary Disease (COPD) (MK-5884-023/RPL554-CO-207) Primary endpoint(s) modified
- Notable: OVERMUSCLED · Combinaison of Virtual Reality and Rehabilitation to Improve Muscle Function, Exercise Tolerance, Exertional Symptoms and Dyspnea · Chronic Respiratory Disease: a Randomized Cross-over Trial Recruitment opened
- Minor: INSPIRE-COPD-E · Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations Primary completion pushed from Sep 1, 2028 to Feb 1, 2029
- Minor: Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES) Start date changed from estimate of Nov 4, 2026 to Oct 28, 2026
- Minor: Patients With COPD and PRISM Trial completed
- Notable: AERODUO-2 · AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients Recruitment opened
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New sponsor entrants, last 90 days sponsors with their first trial in this area
| First posted | Trial | Sponsor | Phase |
|---|---|---|---|
| 2026-11-03 | NCT07914010 Reducing Exposure With Air Cleaners and Technology | University of California, Berkeley new | |
| 2026-11-02 | NCT07908381 A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in… | Enanta Pharmaceuticals, Inc new | Phase 2/3 |
| 2026-10-21 | NCT07886346 COPD Prevalence and Risk Factors Among Saudi Adults Over 18 in Taif | Taif University new | |
| 2026-10-21 | NCT07886502 Upper Airway Morphology and Physiology During Graded Positive Pressure and Nasal High… | Klinikum Dortmund Wirbelsäulenchirurgie new | |
| 2026-10-13 | NCT07871357 Urolithin A Supplementation During Pulmonary Rehabilitation in Patients With COPD | Bryan A. Ross new | Phase 2 |
| 2026-10-09 | NCT07868211 Effect of Dietary Fiber Supplementation on Systemic Inflammation and Clinical Parameters… | Júnea Regina Pires Drews new | |
| 2026-10-09 | NCT07867184 Firefighter's Longitudinal Airway and Respiratory Exposome/Multiome Study (FLARES) | National Institute of Allergy and Infectious Diseases (NIAID) new | |
| 2026-10-02 | NCT07854210 HFNC Versus NIV in Hypercapneic COPD Patients | Mohammed Shehta new | |
| 2026-10-02 | NCT07856667 COINCIDE: Cardineurovascular dIsease and Obstructive Airway Disease | VASCage GmbH new | |
| 2026-10-01 | NCT07852910 Indoor Overheating and Physiological Strain in Older Adults With COPD | University of Ottawa new |
Active trials by phase
| Early Phase 1 | 4 | |
| Phase 1 | 18 | |
| Phase 1/2 | 12 | |
| Phase 2 | 49 | |
| Phase 2/3 | 8 | |
| Phase 3 | 37 | |
| Phase 4 | 31 |
Not charted: 665 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).
Top sponsors by active trials in this area
AstraZeneca (16) · Assiut University (15) · China-Japan Friendship Hospital (11) · Henan University of Traditional Chinese Medicine (11) · VA Office of Research and Development (11) · Riphah International University (10) · GlaxoSmithKline (8) · Haisco Pharmaceutical Group Co., Ltd. (8) · Sanofi (8) · Assistance Publique - Hôpitaux de Paris (7)
Get alerts when COPD trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.